AlphaFold predicted structure
KLHL20 · Q9Y2M5

Mean pLDDT
88.4/ 100
Confident
609 residues
Confidence breakdown
- Very high(≥ 90)75%
- Confident(70–90)16%
- Low(50–70)3%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
kelch like family member 20
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedneurodegenerative disease
neurodevelopmental disorder
Seizure
Intellectual disability
Global developmental delay
complex neurodevelopmental disorder
phlebitis
Thrombophlebitis
hypothyroidism
blood coagulation disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Kelch-like protein 20
Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex involved in interferon response and anterograde Golgi to endosome transport. The BCR(KLHL20) E3 ubiquitin ligase complex mediates the ubiquitination of DAPK1, leading to its degradation by the proteasome, thereby acting as a negative regulator of apoptosis (PubMed:20389280). The BCR(KLHL20) E3 ubiquitin ligase complex also specifically mediates 'Lys-33'-linked ubiquitination (PubMed:24768539). Involved in anterograde Golgi to endosome transport by mediating 'Lys-33'-linked ubiquitination of CORO7, promoting interaction between CORO7 and EPS15, thereby facilitating actin polymerization and post-Golgi trafficking (PubMed:24768539). Also acts as a regulator of endothelial migration during angiogenesis by controlling the activation of Rho GTPases. The BCR(KLHL20) E3 ubiquitin ligase complex acts as a regulator of neurite outgrowth by mediating ubiquitination and degradation of PDZ-RhoGEF/ARHGEF11 (PubMed:21670212). In case of tumor, the BCR(KLHL20) E3 ubiquitin ligase complex is involved in tumor hypoxia: following hypoxia, the BCR(KLHL20)complex mediates ubiquitination and degradation of PML, potentiating HIF-1 signaling and cancer progression (PubMed:21840486)
KLHL20 · Q9Y2M5

Mean pLDDT
88.4/ 100
Confident
609 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0